Abstract
Purpose
We aimed to investigate atypical papillary renal cell carcinoma (PRCC) presenting with early contrast enhancement and late washout and to investigate the correlation between the CT attenuation value of the corticomedullary phase (CMP) of contrast-enhanced CT in PRCCs and the endothelial cell counts of these tumors.
Methods
Twenty-two patients with pathologically confirmed PRCC were enrolled in this study. PRCCs were categorized into 18 typical PRCCs and 4 atypical PRCCs. The CT attenuation value of the lesion in the CMP was measured in the maximal section of the tumor using the region of interest. Microvessel density (MVD) was evaluated as a histopathologic parameter using tissue specimens immunohistochemically stained with an anti-ERG antibody. The CT attenuation value and MVD were compared between atypical and typical PRCCs using the Mann–Whitney U test, where p < 0.05 was considered significant. The correlations between CT attenuation value and MVD were evaluated in all PRCCs using single linear regression analysis.
Results
The mean CT attenuation value and the MVD were significantly higher in atypical than in typical PRCCs. Correlation analyses revealed a weak positive correlation between the CT attenuation value and MVD.
Conclusions
We confirmed several cases of atypical PRCC that present with early contrast enhancement, such as clear cell renal cell carcinoma. In addition, a positive correlation was found between the CT attenuation value in the CMP of PRCCs and the vascular endothelial cell count.
Similar content being viewed by others
Abbreviations
- CCRCC:
-
Clear cell renal cell carcinoma
- CMP:
-
Corticomedullary phase
- CT:
-
Computed tomography
- HU:
-
Hounsfield unit
- MVD:
-
Microvessel density
- PRCC:
-
Papillary renal cell carcinoma
- RCC:
-
Renal cell carcinoma
- ROI:
-
Region of interest
- TDC:
-
Time density curve
References
Soyer P, Dufresne A, Klein I, Barbagelatta M, Hervé JM, Scherrer A. Renal cell carcinoma of clear type: correlation of CT features with tumor size, architectural patterns, and pathologic staging. Eur Radiol, 1997, 7(2):224-229.
Amin MB, Corless CL, Renshaw AA, Tickoo SK, Kubus J, Schultz DS. Papillary (chromophil) renal cell carcinoma: histomorphologic characteristics and evaluation of conventional pathologic prognostic parameters in 62 cases. Am J Surg Pathol, 1997, 21(6):621-635.
Delahunt B, Eble JN. Papillary renal cell carcinoma: a clinicopathologic and immunohistochemical study of 105 tumors. Mod Pathol, 1997, 10(6):537-544.
Renshaw AA, Corless CL. Papillary renal cell carcinoma. Histology and immunohistochemistry. Am J Surg Pathol, 1995, 19(7):842-849.
Choyke PL, Walther MM, Glenn GM, et al. Imaging features of hereditary papillary renal cancers. J Comput Assist Tomogr, 1997, 21(5):737-741.
Roberts SC 3rd, Winick AB, Santi MR. Residents’ teaching files. Papillary renal cell carcinoma: diagnostic dilemma of a cystic renal mass. Radiographics, 1997, 17(4):993-998.
Jinzaki M, Tanimoto A, Mukai M, et al. Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumor angiogenesis. J Comput Assist Tomogr, 2000, 24(6):835-842.
Prasad SR, Humphrey PA, Catena JR, et al. Common and uncommon histologic subtypes of renal cell carcinoma: imaging spectrum with pathologic correlation. Radiographics, 2006, 26(6):1795-1806; discussion 1806-1810.
Fujimoto H, Wakao F, Moriyama N, Tobisu K, Sakamoto M, Kakizoe T. Alveolar architecture of clear cell renal carcinomas (< or = 5.0 cm) show high attenuation on dynamic CT scanning. Jpn J Clin Oncol, 1999, 29(4):198–203.
Wildberger JE, Adam G, Boeckmann W, et al. Computed tomography characterization of renal cell tumors in correlation with histopathology. Invest Radiol, 1997, 32(10):596-601.
Kim JK, Kim TK, Ahn HJ, Kim CS, Kim KR, Cho KS. Differentiation of subtypes of renal cell carcinoma on helical CT scans. AJR Am J Roentgenol, 2002, 178(6):1499-1506.
Ruppert-Kohlmayr AJ, Uggowitzer M, Meissnitzer T, Ruppert G. Differentiation of renal clear cell carcinoma and renal papillary carcinoma using quantitative CT enhancement parameters. AJR Am J Roentgenol, 2004, 183(5):1387-1391.
Yang CW, Shen SH, Chang YH, et al. Are there useful CT features to differentiate renal cell carcinoma from lipid-poor renal angiomyolipoma? AJR Am J Roentgenol, 2013, 201(5):1017-1028.
Lee-Felker SA, Felker ER, Tan N, et al. Qualitative and quantitative MDCT features for differentiating clear cell renal cell carcinoma from other solid renal cortical masses. AJR Am J Roentgenol, 2014, 203(5):W516-524.
Sasaguri K, Takahashi N, Gomez-Cardona D, et al. Small (< 4 cm) renal mass: differentiation of oncocytoma from renal cell carcinoma on biphasic contrast-enhanced CT. AJR Am J Roentgenol, 2015, 205(5):999-1007.
Kim SH, Kim CS, Kim MJ, Cho JY, Cho SH. Differentiation of clear cell renal cell carcinoma from other subtypes and fat-poor angiomyolipoma by use of quantitative enhancement measurement during three-phase MDCT. AJR Am J Roentgenol, 2016, 206(1):W21-28.
Dilauro M, Quon M, McInnes MD, et al. Comparison of contrast-enhanced multiphase renal protocol CT versus MRI for diagnosis of papillary renal cell carcinoma. AJR Am J Roentgenol, 2016, 206(2):319-325.
Russo P. Renal cell carcinoma: presentation, staging, and surgical treatment. Semin Oncol, 2000, 27(2):160-176.
Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology, 2013, 267(2):444-453.
Vikram R, Ng CS, Tamboli P, et al. Papillary renal cell carcinoma: radiologic-pathologic correlation and spectrum of disease. Radiographics, 2009, 29(3):741-754; discussion 755-757.
Hötker AM, Mazaheri Y, Wibmer A, et al. Differentiation of clear cell renal cell carcinoma from other renal cortical tumors by use of a quantitative multiparametric MRI approach. AJR Am J Roentgenol, 2017, 208(3):W85-W91.
Moch H, Humphrey PA, Ulbright TM, Reuter VE, eds (2016) WHO classification of tumours of the urinary system and male genital organs, 4th edn. Lyon, France: International Agency for Research on Cancer.
Shuch B, Amin A, Armstrong AJ, et al. Understanding pathologic variants of renal cell carcinoma: distilling therapeutic opportunities from biologic complexity. Eur Urol, 2015, 67(1):85-97.
Akhtar M, AI-Bozom IA, AI Hussain T. Papillary renal cell carcinoma (PRCC): An update. Adv Anat Pathol, 2019, 26(2):124-132.
Acknowledgements
The authors thank Mrs. Hiromi Ito for editing the manuscript.
Funding
This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors of this manuscript declare no relationships with any companies whose products or services may be related to the subject matter of the article.
Ethics approval
This retrospective study was approved by the institutional review board with a waiver of written informed consent.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yamamoto, T., Gulanbar, A., Hayashi, K. et al. Is hypervascular papillary renal cell carcinoma present?. Abdom Radiol 46, 1687–1693 (2021). https://doi.org/10.1007/s00261-020-02809-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-020-02809-8